DK452089D0 - USE OF ACE INHIBITORS - Google Patents

USE OF ACE INHIBITORS

Info

Publication number
DK452089D0
DK452089D0 DK452089A DK452089A DK452089D0 DK 452089 D0 DK452089 D0 DK 452089D0 DK 452089 A DK452089 A DK 452089A DK 452089 A DK452089 A DK 452089A DK 452089 D0 DK452089 D0 DK 452089D0
Authority
DK
Denmark
Prior art keywords
vessel
ace inhibitors
prevention
neointima
formation
Prior art date
Application number
DK452089A
Other languages
Danish (da)
Other versions
DK452089A (en
Inventor
Hans Rudolf Baumgartner
Jean-Paul Clozel
Fridolin Hefti
Markus Hosang
Herbert Kuhn
Rita Mueller
Jerry Powell
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK452089D0 publication Critical patent/DK452089D0/en
Publication of DK452089A publication Critical patent/DK452089A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

ACE inhibitors are able to suppress the formation of neointima and the reduction of the vessel volume owing to vessel wall thickening after a vessel injury. They are accordingly suitable for the treatment and prevention of neointima formation after vessel injury, in particular for the prevention of arterial restenosis after angioplasty or of vessel wall thickening after vascular surgery in arteries and veins.
DK452089A 1988-09-14 1989-09-13 USE OF ACE INHIBITORS DK452089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH342188 1988-09-14

Publications (2)

Publication Number Publication Date
DK452089D0 true DK452089D0 (en) 1989-09-13
DK452089A DK452089A (en) 1990-03-15

Family

ID=4255625

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452089A DK452089A (en) 1988-09-14 1989-09-13 USE OF ACE INHIBITORS

Country Status (13)

Country Link
EP (1) EP0363671B1 (en)
JP (1) JPH02121922A (en)
KR (1) KR900004337A (en)
AT (1) ATE100716T1 (en)
AU (1) AU625693B2 (en)
DE (1) DE58906814D1 (en)
DK (1) DK452089A (en)
ES (1) ES2061853T3 (en)
HU (1) HU206186B (en)
IE (1) IE892931L (en)
IL (1) IL91572A (en)
PT (1) PT91705B (en)
ZA (1) ZA896851B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925759A1 (en) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE
DE3926606A1 (en) * 1989-08-11 1991-02-14 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
CA2042159A1 (en) * 1990-05-31 1991-12-01 Miguel A. Ondetti Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
ES2109752T3 (en) 1994-05-19 1998-01-16 Mitsubishi Chem Corp MEDICATION FOR THERAPEUTIC AND PROPHYLACTIC TREATMENT OF DISEASES CAUSED BY HYPERPLASIA OF THE SMOOTH MUSCLE CELLS.
ES2161354T3 (en) * 1995-03-24 2001-12-01 Molecumetics Ltd MIMETIC COMPOUNDS OF THE BETA SHEET AND ITS USE AS PROTEASE INHIBITORS.
CA2214759C (en) * 1996-01-17 2004-05-18 Taiho Pharmaceutical Co., Ltd. Intimal hypertrophy inhibitors
SI1216038T1 (en) * 1999-08-30 2006-02-28 Sanofi Aventis Deutschland Ramipril for the prevention of cardiovascular events
JP4904859B2 (en) * 2006-03-13 2012-03-28 大日本印刷株式会社 Printing unit and doctor blade polishing method
CN101478983A (en) * 2006-07-10 2009-07-08 特瓦制药工业有限公司 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
AT377496B (en) 1981-06-19 1985-03-25 Voith Gmbh J M DEVICE FOR WINDING A TRACK OF GOODS ON A NEWLY INSERTED WRAPPING SLEEVE IN A DOUBLE-CARRIER ROLLING MACHINE

Also Published As

Publication number Publication date
KR900004337A (en) 1990-04-12
EP0363671B1 (en) 1994-01-26
PT91705A (en) 1990-03-30
AU625693B2 (en) 1992-07-16
AU4124089A (en) 1990-03-22
ATE100716T1 (en) 1994-02-15
DE58906814D1 (en) 1994-03-10
PT91705B (en) 1995-05-31
ZA896851B (en) 1990-06-27
HU206186B (en) 1992-09-28
JPH02121922A (en) 1990-05-09
EP0363671A3 (en) 1991-12-11
IL91572A (en) 1994-01-25
IL91572A0 (en) 1990-04-29
IE892931L (en) 1990-03-14
DK452089A (en) 1990-03-15
ES2061853T3 (en) 1994-12-16
HUT51148A (en) 1990-04-28
EP0363671A2 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
DK452089D0 (en) USE OF ACE INHIBITORS
NO165986C (en) PROTECTED ARTICLE.
DE68915878D1 (en) Vascular catheter.
PT91863A (en) PREPARATION PROCESS OF A PHARMACEUTICAL PREPARATION BASED ON RANGE-INTERFERENCE
ATE253076T1 (en) ANTITHROMBOTIC DRUGS
NO985463D0 (en) Compounds and methods for treating or preventing diseases of body passageways
DE69121704D1 (en) COMBINATION CATHETER FOR OBSERVATION AND DILATION OF BLOOD VESSELS
DE69222264T2 (en) Vascular access catheter
ATE216888T1 (en) DESFERRI-EXOCHELINE FOR THE TREATMENT OF ATHEROSCLERosis AND VASCULAR DAMAGE BY PREVENTING SMOOTH MUSCLE CELL PROLIFERATION
DE69224983D1 (en) ANTI-GROWTH FACTOR ANTIBODIES IN THE TREATMENT OF Vascular Stenosis
DK0661981T3 (en) Use of hyaluronic acid and its derivatives for the prevention of arterial restenosis
NO924637L (en) PROCEDURE FOR PREVENTING REPEATING OF ARTERIES
UA37249C2 (en) Method for inhibiting stenosis and/or restenosis (variants), method for inhibiting restenosis upon surgery of coronary artery (variants), method for decreasing risk of non-acute ischemic complication upon reconstructive vascular surgery
FR2669826B1 (en) CATHETER FOR DILATION OF THE ARTERIES.
DK448289D0 (en) COMBINED TREATMENT OF ARTERIA FEMORALIS SUPERFICIALIS OCCLUSION WITH PERCUTANEOUS TRANSLUMINAL ANGIOPLASTICS AND LOCALLY INCLUDED RECOMMINATED PLASMINOGEN ACTIVATOR 4 LUMEN OR MORE LUMINA WITH 2 OR MORE BALLETS BALLONES.
RU93056862A (en) METHOD FOR PREVENTING RESTENOSIS OR REDUCING ITS DEGREE
RU93015924A (en) METHOD OF TREATMENT OF TROPHIC ULCERS OF THE LOWER EXTREMITIES

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment